As reported from the ecological study by the International Study on Salt and Blood Pressure (INTERSALT), there is a strong positive correlation between salt intake and blood pressure (BP) levels. 1 A recent large-scale meta-analysis of cross-sectional studies indicated that a 1-g increment in estimated urinary sodium (Na) excretion corresponds to a 2.11 mm Hg increase in systolic BP (SBP) and a 0.78 mm Hg increase in diastolic BP and that this association was most pronounced in persons consuming high-sodium diets, with hypertension, or of older age. 2 In contrast to the accumulating evidence from the ecological and cross-sectional investigations including our earlier report, 3 data regarding the prognostic significance of excessive Na intake with regards to increasing BP levels or the onset of hypertension are limited. A population-based study in Chinese 4 reported a J-shaped relationship between urinary Na levels and the incidence of hypertension, and a study in a European population observed a positive association between Na excretion levels and the onset of hypertension only in cases with higher serum uric acid or urinary albumin excretion levels. 5 Given the inconsistency of previous results, further studies are required to confirm the prognostic significance of urinary Na excretion for longitudinal changes in BP traits.
As reported from the ecological study by the International Study on Salt and Blood Pressure (INTERSALT), there is a strong positive correlation between salt intake and blood pressure (BP) levels. 1 A recent large-scale meta-analysis of cross-sectional studies indicated that a 1-g increment in estimated urinary sodium (Na) excretion corresponds to a 2.11 mm Hg increase in systolic BP (SBP) and a 0.78 mm Hg increase in diastolic BP and that this association was most pronounced in persons consuming high-sodium diets, with hypertension, or of older age. 2 In contrast to the accumulating evidence from the ecological and cross-sectional investigations including our earlier report, 3 data regarding the prognostic significance of excessive Na intake with regards to increasing BP levels or the onset of hypertension are limited. A population-based study in Chinese 4 reported a J-shaped relationship between urinary Na levels and the incidence of hypertension, and a study in a European population observed a positive association between Na excretion levels and the onset of hypertension only in cases with higher serum uric acid or urinary albumin excretion levels. 5 Given the inconsistency of previous results, further studies are required to confirm the prognostic significance of urinary Na excretion for longitudinal changes in BP traits.
The most reliable method for estimating daily salt intake in both clinical and epidemiological settings is the measurement of 24-hour urinary Na excretion. However, 24-hour urine collection is inconvenient for participants and cannot be easily adapted for large-scale cohort studies. Another simple method of estimating daily salt intake is the use of the equations developed by Kawasaki et al. 6 or Tanaka et al., 7 which can estimate 24-hour urinary Na and potassium (K) excretion from spot urine samples. Although these equations are easy to use and have been adopted in several epidemiological studies, 2 the accuracy of estimation is limited due to the large discrepancy between actual and estimated 24-hour Na and K excretion levels. 6, 7 Recently, we reported that the spot urine sodium-to-potassium ratio (Na/K) is more closely associated with BP levels than estimated daily salt intake in a cross-sectional analysis. 3 Further, this positive association was found to be independent of many clinical and environmental factors, including fasting conditions. However, prognostic significance of spot urine Na/K for BP traits is largely unknown. Clarifying whether and how accurately spot urine Na/K can estimate longitudinal changes in BP traits is required to use it as a marker of salt loading.
The aim of the present study was to clarify the prognostic significance of the spot urine Na/K in detecting longitudinal increases in BP levels in a large-scale general population. As high urinary Na excretion, as well as lower K excretion, has been posited as a risk factor for renal functional decline in patients with chronic kidney diseases (CKD) 8 and in the general population, 9 we further investigated the longitudinal relationship between the spot urine Na/K and renal function.
METHODS

Cohort participants
We analyzed a dataset describing participants in the Nagahama Prospective Cohort for Comprehensive Human Bioscience (the Nagahama Study). Participants in this community-based prospective cohort study were recruited between 2008 and 2010 from the general population of Nagahama City, a rural city of 125,000 inhabitants located in central Japan. Community residents from 30 to 74 years of age, living independently, and without physical impairment or dysfunction were eligible. Of the 9,804 included participants, 9 withdrew consent to participate, and 26 were excluded due to genetic analysis demonstrating a differing ethnic background. Thus, the total number of current cohort participants is 9,769.
All study procedures were approved by the ethics committee of Kyoto University Graduate School of Medicine and by the Nagahama Municipal Review Board. Written informed consent was obtained from all participants.
Follow-up measurements
Participants in the Nagahama cohort were invited to a follow-up assessment 5 years after baseline evaluations, and 8,294 of the original 9,769 cohort members participated. After excluding 137 individuals who died and 279 who had moved away from Nagahama City, the follow-up rate was 88.7%.
Study participants
Among the 8,294 participants in the follow-up investigation, individuals who met the following criteria in either baseline or follow-up measurements were excluded from the analysis; pregnant women (n = 55), insulin therapy (n = 51) or hemodialysis (n = 7), pacemaker implantation (n = 11), history of cardiovascular diseases (n = 423), lack of urine sample due to menstruation (n = 581), and incomplete or wide deviation of clinical values required for the present study (n = 41). Individuals with severe renal functional decline at baseline (estimated glomerular filtration rate [eGFR] <40 ml/min/1.73 m 2 or urinary albumin ≥500 mg/day, n = 62) were also excluded. The remaining 7,063 individuals were ultimately included in the present study. The mean follow-up duration in this subpopulation was 1,813 ± 133 days (5-year interval, n = 6,805; 6-year interval n = 246; and 7-year interval n = 12). Clinical measurements and peripheral blood collection were performed in substantial number of subjects under nonfasted (<4 hours; baseline, n = 564; follow-up, n = 294) or near-fasting (4-11 hours; baseline, n = 3,209; follow-up, n = 1,646) conditions.
Spot urine sample
Spot urine samples were collected between 9:00 am and 5:00 pm, and urinary Na, K, and creatinine (Cre) levels were measured on the day of sampling. The time from the last meal was recorded for each subject.
Clinical measurement
Brachial BP was measured twice using an automatic cuffoscillometric device (HEM9000-AI, Omron Healthcare, Kyoto, Japan) in the sitting position, and mean BP values were used in the analysis. Hypertension was defined SBP ≥140 mm Hg, diastolic BP ≥90 mm Hg, or current use of antihypertensive drugs.
Renal function was assessed by eGFR calculated according to the following equation; 194 × Cre −1.094 × age −0.287 × 0.739 [if female]. 10 A criterion defined by the Japanese Society of Nephrology (G1, ≥ 90; G2, 60-89; G3a, 45-59; G3b, 30-44; G4, 15-29; G5 <15 ml/min/1.73 m 2 ) was used for categorization. CKD was defined as either or both of eGFR <60 ml/min/1.73 m 2 and urinary albumin ≥30 mg/day.
Body height and weight were measured using standard digital stadiometer and weight scale to one decimal place. Body mass index was calculated by dividing body weight (kg) by squared body height (m 2 ).
Smoking habit, alcohol consumption, history of cardiovascular disease, and medication usage were assessed using a structured self-administered questionnaire. Alcohol consumption was calculated based on the amount consumed in a single sitting and was described in Japanese traditional units of alcohol (Go), where 1 Go corresponds to 22 g of ethanol.
Statistical analysis
Values were expressed as mean ± SD. Changes in clinical parameters between the follow-up period was assessed by a paired t-test or McNemar's test. Group differences in numeric variables were assessed by analysis of variance. Quartiles of Na/K were calculated separately for each sex and then combined to avoid potential sex differences. Concordance between Na/K quartiles at baseline and followup was assessed using the kappa statistic. Factors independently associated with SBP and eGFR were assessed using a linear mixed model by considering measurement time as a random effect. Multivariate analysis of variance was used to identify factors associated with repeated measured SBP and eGFR. The statistical analysis was performed using JMP ver. 12.2.0 software (SAS Institute, Cary, NC, USA). P-values <0.05 were considered statistically significant.
RESULTS
Clinical characteristics of the study subjects are shown in Table 1 . The frequency of hypertension was higher at the time of follow-up, partly due to the increased number of individuals taking antihypertensive drugs. When individuals who started (n = 638) or discontinued (n = 61) antihypertensive medication during the follow-up period were excluded from the calculation, the mean SBP values at baseline and at follow-up were 122 ± 16 mm Hg and 124 ± 18 mm Hg, respectively, while those in nontreated subjects were 119 ± 15 mm Hg and 122 ± 17 mm Hg, respectively.
No marked differences in serum Cre levels were observed between baseline and follow-up measurements, while eGFR was slightly decreased at the time of follow-up, possibly due to population aging. The mean urinary albumin level was slightly higher at follow-up in contrast to the lower frequency of microalbuminuria (≥30 mg/day; baseline, 8.0%; follow-up, 7.5%). The slightly higher frequency of CKD at the time of follow-up may, therefore, be attributable to decreased eGFR levels.
There was a significant but modest reproducibility between Na/K quartiles at baseline and follow-up measurements (Figure 1a) . The reproducibility was slightly better in cases where urine sample were obtained under fasting condition for either measurements (Figure 1b) , but not in cases that were not receiving antihypertensive drugs (κ = 0.087). Regression coefficient of baseline Na/K on the follow-up Na/K was 0.231, while that of SBP was 0.715.
Na/K ratio and BP
In a cross-sectional analysis, the spot urine Na/K was positively associated with SBP at both baseline (r = 0.134, P < 0.001) and follow-up (r = 0.155, P < 0.001). This positive association was confirmed by a linear mixed model analysis using the overall data ( Table 2) . Values are presented as means ± SD or frequency. Statistical significance was assessed by paired t-test or McNemar's test. Hypertension comprised systolic blood pressure (BP) ≥140 mm Hg, diastolic BP ≥90 mm Hg, or antihypertensive treatment. Estimated glomerular filtration rate (eGFR) was calculated using the following formula: 194 × serum creatinine −1.094 × age −0.287 × 0.739 (if female). Chronic kidney disease (CKD) was defined as either or all of eGFR <60 ml/min/1.73 m 2 , or urinary albumin ≥30 mg/day. Alcohol consumption was calculated based on the amount consumed in a single sitting and was described in Japanese traditional units of alcohol (Go), where 1 Go corresponds to 22 g of ethanol.
Table 3 summarizes differences in BP levels by the Na/K quartiles. Baseline BP levels were significantly different by baseline Na/K quartiles, though the differences in follow-up BP levels were modest. Figure 2a depicted differences in longitudinal SBP change during the follow-up period by baseline Na/K quartile. Individuals with higher baseline Na/K thus showed larger SBP decline in either analysis for Na/K quartiles (Figure 2a) or Na/K continuous value (r = −0.107, P < 0.001). Results of multivariate analysis for repeated measured SBP (Table 4) identified baseline Na/K * time interaction term (intraindividual effect) as an inverse determinant independently of the positive association of baseline Na/K (interindividual effect) irrespective of hypertensive status, antihypertensive drug usage, and fasting condition. When a subanalysis was performed in individuals those were categorized in the same Na/K quartile at both baseline and followup, baseline Na/K * time interaction term was not identified as a significant determinant.
Na/K and renal function
Baseline urinary Na to Cre ratio (Na/Cre) was positively associated with eGFR (G1, 2.1 ± 1.1 (n = 1,646); G2, 1.8 ± 0.9 (n = 4,842); ≤G3a, 1.6 ± 0.9 (n = 575); F = 77.6; P < 0.001). As group differences in the Na/Cre were larger than that of the K to Cre ratio (K/Cre) (G1, 0.7 ± 0.3; G2, 0.6 ± 0.3; ≤G3a, 0.6 ± 0.2; F = 15.4; P < 0.001), individuals with greater eGFR exhibited higher Na/K values (G1, 3.5 ± 2.1; G2, 3.1 ± 1.8; ≤G3a: 2.8 ± 1.6; F = 38.6; P < 0.001). Results of linear mixed model using overall data identified urinary Na/K as a positive independent determinant for eGFR (Table 2) .
Differences in longitudinal changes in eGFR by baseline Na/K quartile was depicted in Figure 2b . Because differences in baseline eGFR among the Na/K quartiles were larger than that measured at follow-up (Table 3) , higher baseline Na/K was associated with greater eGFR decline. Results of the multivariate analysis for repeated measured The linear mixed model includes measurement time as a random effect. Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic BP; eGFR, estimated glomerular filtration rate; SBP, systolic BP. Figure 1 . The reproducibility of the spot urine Na/K at baseline and at follow-up. (a) total population, (b) individuals whose urine samples were collected after at least 4 hours from the last meal at both baseline and follow-up. Na/K quartiles were calculated within sex and then combined to avoid potential sex differences. The numbers of study participants in each subgroup are shown in columns. Concordance between Na/K quartiles between baseline and follow-up values was assessed using the kappa statistic.
eGFR (Table 4 ) thus identified baseline Na/K * time interaction term as an inverse determinant independently of baseline Na/K. When Na (Na/Cre * time: estimates = −1.520, P < 0.001) or K (K/Cre * time: estimates = −1.320, P < 0.001) were separately included in the regression model instead of Na/K, these factors were also identified as inverse determinants. However, in an analysis in individuals those were categorized in the same Na/K quartile at both baseline and follow-up, no significant association was observed between baseline Na/K * time interaction term and repeated measured eGFR.
DISCUSSION
In this large-scale longitudinal study, we demonstrated that the spot urine Na/K was positively associated with BP levels in a cross-sectional setting. However, it may be difficult to evaluate longitudinal changes in BP levels using the 1-point measured urinary Na/K. The spot urine Na and Na/K values may also not have sufficient prognostic utility in assessing renal functional decline.
The inverse association between baseline Na/K and longitudinal changes in BP might be due to an effect of regression toward to the mean, i.e., if the Na/K was high on first measurement, it would tend to be closer to the average on second measurement, thereby giving rise to an inverse association between baseline Na/K and SBP at follow-up. Given that regression slope between baseline and follow-up values of Na/K was shallower than that of BP, poor reproducibility of urinary Na/K might be a primary reason for the inverse association. This consideration was supported by the result of subanalysis in individuals belonging to the same Na/K quartile at both measurement that indicated a lack of association between baseline Na/K and longitudinal changes in SBP. Although baseline Na/K was significantly associated with eGFR decline, this apparent relationship might also be due to an effect of regression to the mean resulting from the positive association between Na/K and eGFR at baseline, but might not represent a pathophysiological relationship. Relationship between urinary Na excretion level and future BP or incidence of hypertension may depend on the method of urine sample collection and analysis. A large-scale Values are mean ± SD. Statistical significance was assessed by analysis of variance. Quartiles of Na/K were calculated separately for each sex and then combined to avoid potential sex differences. Abbreviations: ANOVA, analysis of variance; BP, blood pressure; DBP, diastolic BP; eGFR, estimated glomerular filtration rate; SBP, systolic BP. study in European populations reported a positive association between changes in SBP levels and increases in 24-hour urine sodium excretion during the follow-up period. 11 Recently, Takase et al. 12 reported that both higher baseline sodium intake and gradual increases in sodium intake during the follow-up period estimated from spot urine samples were significantly associated with the incidence of hypertension independently of baseline BP levels in Japanese. Results of these studies and our linear mixed model are commonly indicating a basic physiological relationship between salt intake and BP levels at measurement. In contrast, results for the prognostic significance of urinary Na/K are currently confusing. Chien et al. 4 reported a positive association between Na excretion levels in overnight urine sample and incidence of hypertension in a Taiwanese general population. Given that baseline relationship between Na/K and BP was curiously insignificant in their study setting, an effect of regression toward to the mean might not confound in the longitudinal relationships. Forman et al. 5 found a positive association of sodium intake levels calculated from Na excretion levels in 2-days 24-hour urine sample with incidence of hypertension in a European general population. However, as they did not adjust baseline BP in their multivariate model, the results cannot be simply compared with present findings. Given these previous results and our present findings, it may difficult to assess longitudinal risk for developing hypertension by a few measurements of urinary sodium levels.
The reproducibility of the spot urine Na/K between baseline and follow-up measurements was modest which might also be a potential reason for the poor prognostic significance of urinary Na/K. A major reason for the moderate reproducibility may be intraindividual differences in daily salt intake. In addition, individuals with higher Na/K values at baseline may be more likely to undergo unidentifiable improvements, such as in lifestyle habits. The mechanisms by which sodium Estimates indicates M-transformed parameter estimates. The numbers of study participants in each model are shown in parentheses. Adjusted factors were as follows; SBP: age, sex, BMI, alcohol consumption at baseline, and interaction term of each factors with time; eGFR: age, sex, BMI, alcohol consumption, SBP at baseline, and interaction term of each factors with time. Sensitivity analyses was performed under the following conditions; A: normotensive at baseline (SBP < 140 mm Hg, DBP < 90 mm Hg, and not receiving antihypertensive drugs); B, F: not receiving antihypertensive drugs at baseline or at follow-up; C, G: whose urine sample was obtained under near-fasting or fasting conditions (≥4 hours after last meal); D, H: categorized in the same Na/K quartiles at baseline and at follow-up; E: eGFR ≥60 ml/min/1.73 m 2 . Abbreviations: eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure. increases BP are multifactorial nature of neurohumoral factors involved in sodium metabolism, including both sodium reabsorption promoting factors (e.g., renin-angiotensin system and sympathetic nervous activity) and inhibiting factors (e.g., natriuretic peptide and nitric oxide). 13 These factors have also been posited as a cause of interindividual differences in salt sensitivity, which also increases the difficulty of prediction of longitudinal BP change by a single-measured urinary Na/K. Further, large intraindividual differences between the spot urine Na/K and 24-hour urinary Na/K in individuals who had a higher mean urinary Na/K 14 may also be a factor that limits the prognostic utility of the spot urine Na/K. A few points measured urinary sodium levels may therefore not be a good prognostic marker regardless of the measurement method, though repeated measures of random urine samples have been recently reported to give a close estimation of the 24-hour urine Na/K. 15 In patients with CKD, the prognostic significance of urinary Na level for renal functional decline remains controversial. Several studies have reported that high urinary Na, 1, 6, 16 or both high Na and low K, 9 may be a risk factor for progression to end-stage renal diseases, 17 CKD progression, 9 and mortality, 16 whereas other studies 18, 19 have reported no evidence of these associations irrespective of ethnic differences. In contrast, in the general population, 10 as well as in patients at risk for cardiovascular diseases but with preserved renal function, 20,21 low urinary K levels rather than high Na levels has been suggested as a risk factors for CKD 10 and renal outcomes. 20, 21 Although the settings of these previous studies were not fully consistent with that of the present study, particularly regarding urinary sample collection, our results also showed inverse association between Na/K and longitudinal decline of renal function. However, given the results of regression analysis for SBP, this inverse association might partially result from an effect of regression toward to the mean. Although slower renal functional decline in individuals with high urinary potassium was strongly supported by a longitudinal study using multi-day 24-hour urine sample, 21 this predictability may not be extrapolated to other studies using a spot urine sample.
Several limitations of the present study warrant mention. First, the follow-up period (5.0 years) was somewhat shorter, which raised ambiguity in the diagnoses of hypertension and CKD in individuals with borderline measurements. We, therefore, adopted multivariate analysis of variance for repeated measured BP levels and eGFR values instead of using the incidences of hypertension or CKD (dichotomic variables) as an outcome. Second, although size of our study population was large, only 2-point measured urinary sample was available. Time-series analysis using multipoint data may help further clarify the relations between the spot urine Na/K and longitudinal changes in BP and eGFR.
In summary, the spot urine Na/K was a significantly associated with current BP levels and may, therefore, have utility in evaluating the effect of salt load on BP levels in a cross-sectional manner. In contrast, it may be difficult to assess salt-overloading risk for longitudinal BP change by single-point measured Na/K values, although a possibility that repeated measures of urinary Na/K may improve the prognostic significance is leaving. The spot urinary Na levels and Na/K may also not be a good marker in assessing renal functional decline.
